IGM Biosciences Inc (IGMS)
NASDAQ:IGMS
Holding IGMS?
Track your performance easily

IGM Biosciences (IGMS) Financial Statements

300 Followers

IGM Biosciences Financial Overview

IGM Biosciences's market cap is currently ―. The company's EPS TTM is $-3.676; its P/E ratio is -4.53; IGM Biosciences is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.79. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-$ 497.00K$ -957.00K--
Gross Profit-----
EBIT$ -47.90M$ -53.86M$ -65.12M$ -61.75M$ -64.31M
EBITDA$ -43.36M$ -51.68M$ -62.94M$ -61.84M$ -64.45M
Net Income Common Stockholders$ -47.90M$ -49.82M$ -60.70M$ -61.99M$ -64.42M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 256.38M$ 293.77M$ 337.68M$ 386.99M$ 386.87M
Total Assets$ 336.50M$ 376.13M$ 423.41M$ 474.35M$ 480.66M
Total Debt$ 39.37M$ 40.93M$ 40.51M$ 41.19M$ 41.42M
Net Debt$ -217.01M$ -252.84M$ -297.17M$ -345.80M$ -345.45M
Total Liabilities$ 214.14M$ 214.88M$ 220.18M$ 220.49M$ 222.05M
Stockholders Equity$ 122.36M$ 161.00M$ 203.23M$ 253.86M$ 258.41M
Cash Flow-
Free Cash Flow$ -38.56M$ -44.90M$ -49.46M$ -43.20M$ -57.02M
Operating Cash Flow$ -37.37M$ -42.42M$ -48.01M$ -40.12M$ -53.10M
Investing Cash Flow$ 24.52M$ 8.65M$ -14.69M$ 19.55M$ -6.33M
Financing Cash Flow$ 615.00K$ 152.00K$ 402.00K$ 44.64M$ 69.95M
Currency in USD

IGM Biosciences Earnings and Revenue History

IGM Biosciences Debt to Assets

IGM Biosciences Cash Flow

IGM Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis